CEACAM5 and colorectal carcinoma: In spite of the scarce quantitative studies regarding the improved performance of CEA cancer-associated glycoforms over the conventional total CEA concentration assay, the above-referred studies corroborate the importance of glycosylation analysis of CEA to enhance the clinical performance of this CRC biomarker.